furosemide and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid

furosemide has been researched along with 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, JW; Curtis, AJ; Lim, CF; Stockigt, JR; Topliss, DJ; Wynne, KN1
Kawai, K; Nishii, R; Nishio, T; Takamura, N; Tokunaga, J; Yoshimoto, M1

Trials

1 trial(s) available for furosemide and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid

ArticleYear
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:7

    Topics: Adult; Aged; Barbiturates; Binding Sites; Carbon Radioisotopes; Diazepam; Diuretics; Fatty Acids, Nonesterified; Female; Furans; Furosemide; Hippurates; Humans; Indican; Kidney Failure, Chronic; Male; Middle Aged; Propionates; Protein Binding; Renal Dialysis; Serum Albumin; Treatment Outcome; Warfarin

2008

Other Studies

1 other study(ies) available for furosemide and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid

ArticleYear
A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum.
    Metabolism: clinical and experimental, 1993, Volume: 42, Issue:11

    Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Nonesterified; Furans; Furosemide; Humans; Oleic Acid; Oleic Acids; Phenylacetates; Prealbumin; Propionates; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine

1993